CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies.

MLA

Sun, Jennifer, et al. “CD47-Targeting Antibodies as a Novel Therapeutic Strategy in Hematologic Malignancies.” Leukemia Research Reports, vol. 16, Sept. 2021, p. 100268. EBSCOhost, https://doi.org/10.1016/j.lrr.2021.100268.

APA

Sun, J., Chen, Y., Lubben, B., Adebayo, O., Muz, B., & Azab, A. K. (2021). CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies. Leukemia Research Reports, 16, 100268. https://doi.org/10.1016/j.lrr.2021.100268

Chicago

Sun, Jennifer, Yixuan Chen, Berit Lubben, Ola Adebayo, Barbara Muz, and Abdel Kareem Azab. 2021. “CD47-Targeting Antibodies as a Novel Therapeutic Strategy in Hematologic Malignancies.” Leukemia Research Reports 16 (September): 100268. doi:10.1016/j.lrr.2021.100268.